Chemokines and chemokine receptors in autoimmune encephalomyelitis as a model for central nervous system inflammatory disease regulation

Frontiers in Bioscience

Volumn 9, Issue , 2004, Pages 1500-1505

  Dogan, Rukiye Nazan E ^b   Karpus, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

Autoimmune encephalomyelitis; Central nervous system; Chemokine receptors; Chemokines; Multiple sclerosis; Review

Indexed keywords

ANTIBODY; CHEMOKINE; CHEMOKINE CCL3; CHEMOKINE CXCL10 ANTIBODY; CHEMOKINE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE MODEL; LEUKOCYTE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE ACTIVATION; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; MOUSE; MOUSE MUTANT; PHYSIOLOGY;

ANIMALIA;

ANIMALS; CENTRAL NERVOUS SYSTEM; CHEMOKINES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MICE; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; RECEPTORS, CHEMOKINE;

EID: 2442700643     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1284     Document Type: Review

References (71)

1. Hickey, W. F.: The pathology of multiple sclerosis: a historical perspective. J Neuroimmunol 98, 37-44 (1999)
2. Trapp, B. D., Bo, L., Mork, S., and Chang, A.: Pathogenesis of tissue injury in MS lesions. J Neuroimmunol 98, 49-56 (1999)
3. Hickey, W. F., Cohen, J. A., and Burns, J. B.: A quantitative immunohistochemical comparison of actively versus adoptively induced experimental allergic encephalomyelitis in the Lewis rat. Cell Immunol 109, 272-281 (1987)
4. Hafler, D. A. and Weiner, H. L.: MS: a CNS and systemic autoimmune disease. Immunol Today 10, 104-107 (1989)
5. Pettinelli, C. B. and McFarlin, D. E.: Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+2- T lymphocytes. J Immunol 127, 1420-(1981)
6. Cross, A. H., Cannella, B., Brosnan, C. F., and Raine, C. S.: Hypothesis: Antigen-specific T cells prime central nervous system endothelium for recruitment of nonspecific inflammatory cells to effect autoimmune demyelination. J Neuroimmunol 33, 237-244 (1991)
7. Benveniste, E. N.: Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 75, 165-173 (1997)
8. Tuohy, V. K., Lu, Z. J., Sobel, R. A., Laursen, R. A., and Lees, M. B.: A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J Immunol 141, 1126-1130 (1988)
9. Whitham, R. H., Jones, R. E., Hashim, G. A., Hoy, C. M., Wang, R.-Y., Vandenbark, A. A., and Offner, H.: Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice. J Immunol 147, 3803-3808 (1991)
10. Amor, S., Groome, N., Linington, C., Morris, M. M., Dornmair, K., Gardinier, M. V., Matthieu, J.-M., and Baker, D.: Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153, 4349-4356 (1994)
11. Pettinelli, C. B., Fritz, R. B., Chou, C. H. J., and McFarlin, D. E.: Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J Immunol, 129, 1209-1211 (1982)
12. Fritz, R. B., Skeen, M. J., Chou, C. H., and Zamvil, S. S.: Localization of an encephalitogenic epitope for the SJL mouse in the N-terminal region of myelin basic protein. J Neuroimmunol 26, 239-243 (1990)
13. Ando, D. G., Clayton, J., Kono, D., Urban, J. L., and Sercarz, E. E.: Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 124, 132-143 (1989)
14. van der Veen, R. C. and Stohlman, S. A.: Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: Relative roles of interleukin (IL)-4 and IL-10. J Neuroimmunol 48, 213-220 (1993)
15. Segal, B. M. and Shevach, E. M.: IL-12 unmasks latent autoimmune disease in resistant mice. J Exp Med 184, 771-775 (1996)
16. Segal, B. M., Dwyer, B. K., and Shevach, E. M.: An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease. J Exp Med 187, 537-546 (1998)
17. Butter, C., Baker, D., O'Neill, J. K., and Turk, J. L.: Mononuclear cell trafficking and plasma extravasation into the CNS during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice. J Neurol Sci 104, 9-12 (1991)
18. Brennan, F. R., O'Neill, J. K., Allen, S. J., Butter, C., Nuki, G., and Baker, D.: CD44 is involved in selective leukocyte extravasation during inflammatory central nervous system disease. Immunol 98, 427-435 (1999)
19. Willenborg, D. O., Fordham, S., Bernard, C. C. A., Cowden, W. B., and Ramshaw, I. A.: IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein- induced autoimmune encephalomyelitis. J Immunol 157, 3223-3227 (1996)
20. Krakowski, M. and Owens, T.: Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 26, 1641-1646 (1996)
21. Mokhtarian, F., McFarlin, D. E., and Raine, C. S.: Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature 309, 356-358 (1984)
22. Hickey, W. F.: Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol 1, 97-105 (1991)
23. Hickey, W. F., Hsu, B. L., and Kimura, H.: T-lymphocyte entry into the central nervous system. J Neurosci Res 28, 254-260 (1991)
24. Hickey, W. F.: Leukocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 11, 125-137 (1999)
25. Carrithers, M. D., Visintin, I., Kang, S. J., and Janeway, C. A., Jr.: Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 123 (Pt 6), 1092-1101 (2000)
26. Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., and Janeway, C. A., Jr.: Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177, 57-68 (1993)
27. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., and Karin, N.: Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 356, 63-66 (1992)
28. Kent, S. J., Karlik, S. J., Cannon, C., Hines, D. K., Yednock, T. A., Fritz, L. C., and Horner, H. C.: A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol 58, 1-10 (1995)
29. Cuzner, M. L. and Opdenakker, G.: Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol 94, 1-14 (1999)
30. NYG, P. T. and Hinkkanen, A. E.: Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis. Clin and Exp Immunol 128, 245-254 (2002)
31. Williams, K. C., Zhao, R. W., Ueno, K., and Hickey, W. F.: PECAM-1 (CD31) expression in the central nervous system and its role in experimental allergic encephalomyelitis in the rat. J Neurosci Res 45, 747-757 (1996)
32. Graesser, Donnasue, Solowiej, Anna, Bruckner, Monika, Osterweil, Emily, Juedes, Amy, Davis, Sandra, Ruddle, Nancy H., Engelhardt, Britta, and Madri, Joseph A.: Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest 109, 383-392 (2002)
33. Kobayashi, Y., Kawai, K., Honda, H., Tomida, S., Niimi, N., Tamatani, T., Miyasaka, M., and Yoshikai, Y.: Antibodies against leukocyte function-associated antigen- 1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis. Cell Immunol 164, 295-305 (1995)
34. Springer, T. A.: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314 (1994)
35. Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., and Power, C. A.: International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52, 145-176 (2000)
36. Zlotnik, A. and Yoshie, O.: Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127 (2000)
37. Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., Chan, S. Y., Roczniak, S., and Shanafelt, A. B.: The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270, 27348-27357 (1995)
38. Davatelis, G., Tekamp-Olson, P., Wolpe, S. D., Hermsen, K., Luedke, C., Gallegos, C., Coit, D., Merryweather, J., and Cerami, A.: Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokine properties. J Exp Med 167, 1939-1944 (1988)
39. Schall, T. J.: Biology of the RANTES/SIS cytokine family. Cytokine 3, 165-183 (1991)
40. Taub, D. D., Conlon, K., Lloyd, A. R., Oppenheim, J. J., and Kelvin, D. J.: Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β. Science 260, 355-358 (1993)
41. Hedrick, J. A., Saylor, V., Figueroa, D., Mizoue, L., Xu, Y. M., Menon, S., Abrams, J., Handel, T., and Zlotnik, A.: Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J Immunol 158, 1533-1540 (1997)
42. Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., and Schall, T. J.: A new class of membrane-bound chemokine with a CX3C motif. Nature 385, 640-644 (1997)
43. Hulkower, K., Brosnan, C. F., Aquino, D. A., Cammer, W., Kulshrestha, S., Guida, M. P., Rapoport, D. A., and Berman, J. W.: Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J Immunol 150, 2525-2533 (1993)
44. Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., Estes, M. L., Thomas, D. M., and Tuohy, V. K.: Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7, 592-600 (1993)
45. Godiska, R., Chantry, D., Dietsch, G. N., and Gray, P. W.: Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 58, 167-176 (1995)
46. Glabinski, A. R., Tani, M., Tuohy, V. K., Tuthill, R. J., and Ransohoff, R. M.: Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain, Behavior, & Immunity 9, 315-330 (1995)
47. Glabinski, A. R., Tuohy, V. K., and Ransohoff, R. M.: Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 5, 166-171 (1998)
48. Glabinski, A. R., Tani, M., Strieter, R. M., Tuohy, V. K., and Ransohoff, R. M.: Synchronous synthesis of α-and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 150, 617-630 (1997)
49. Karpus, W. J., Lukacs, N. W., McRae, B. L., Strieter, R. M., Kunkel, S. L., and Miller, S. D.: An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155, 5003-5010 (1995)
50. Fife, B. T., Kennedy, K. J., Paniagua, M. C., Lukacs, N. W., Kunkel, S. L., Luster, A. D., and Karpus, W. J.: CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166, 7617-7624 (2001)
51. Kennedy, K. J., Strieter, R. M., Kunkel, S. L., Lukacs, N. W., and Karpus, W. J.: Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1. J Neuroimmunol 92, 98-108 (1998)
52. Alt, C., Laschinger, M., and Engelhardt, B.: Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunol 32, 2133-2144 (2002)
53. Bajetto, A., Bonavia, R., Barbero, S., Piccioli, P., Costa, A., Florio, T., and Schettini, G.: Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem 73, 2348-2357 (1999)
54. Maciejewski-Lenoir, D., Chen, S., Feng, L., Maki, R., and Bacon, K. B.: Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J Immunol 163, 1628-1635 (1999)
55. Fife, B. T., Paniagua, M. C., Lukacs, N. W., Kunkel, S. L., and Karpus, W. J.: Selective CC chemokine receptor expression by central nervous system- infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis. J Neurosci Res 66, 705-714 (2001)
56. Glabinski, A. R., Bielecki, B., O'Bryant, S., Selmaj, K., and Ransohoff, R. M.: Experimental autoimmune encephalomyelitis: CC chemokine receptor expression by trafficking cells. J Autoimmun 19, 175-181 (2002)
57. Bagaeva, Ludmila V., Williams, Lucas P., and Segal, Benjamin M.: IL-12 dependent/IFN[gamma] independent expression of CCR5 by myelin-reactive T cells correlates with encephalitogenicity. J Neuroimmunol 137, 109-116 (2003)
58. Fife, B. T., Huffnagle, G. B., Kuziel, W. A., and Karpus, W. J.: CC Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis. J Exp Med 192, 899-906 (2000)
59. Balashov, K. E., Rottman, J. B., Weiner, H. L., and Hancock, W. W.: CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 96, 6873-6878 (1999)
60. Sorensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., Frederiksen, J. L., and Ransohoff, R. M.: Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103, 807-815 (1999)
61. Misu, Tatsuro, Onodera, Hiroshi, Fujihara, Kazuo, Matsushima, Koji, Yoshie, Osamu, Okita, Naoshi, Takase, Sadao, and Itoyama, Yasuto: Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling. J Neuroimmunol 114, 207-212 (2001)
62. Huang, D. R., Wang, J., Kivisakk, P., Rollins, B. J., and Ransohoff, R. M.: Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193, 713-726 (2001)
63. Tran, E. H., Kuziel, W. A., and Owens, T.: Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein- 1alpha or its CCR5 receptor. Eur J Immunol 30, 1410-1415 (2000)
64. Rottman, J. B., Slavin, A. J., Silva, R., Weiner, H. L., Gerard, C. G., and Hancock, W. W.: Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur J Immunol 30, 2372-2377 (2000)
65. Gao, J. L., Wynn, T. A., Chang, Y., Lee, E. J., Broxmeyer, H. E., Cooper, S., Tiffany, H. L., Westphal, H., Kwon-Chung, J., and Murphy, P. M.: Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 185, 1959-1968 (1997)
66. Hesselgesser, J., Ng, H. P., Liang, M., Zheng, W., May, K., Bauman, J. G., Monahan, S., Islam, I., Wei, G. P., Ghannam, A., Taub, D. D., Rosser, M., Snider, R. M., Morrissey, M. M., Perez, H. D., and Horuk, R.: Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. J Biol Chem 273, 15687-15692 (1998)
67. Liang, M., Mallari, C., Rosser, M., Ng, H. P., May, K., Monahan, S., Bauman, J. G., Islam, I., Ghannam, A., Buckman, B., Shaw, K., Wei, G. P., Xu, W., Zhao, Z., Ho, E., Shen, J., Oanh, H., Subramanyam, B., Vergona, R., Taub, D., Dunning, L., Harvey, S., Snider, R. M., Hesselgesser, J., Morrissey, M. M., and Perez, H. D.: Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J Biol Chem 275, 19000-19008 (2000)
68. Karpus, William J., Fife, Brian T., and Kennedy, Kevin J.: Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease. Methods 29, 362-368 (2003)
69. Kohler, Rachel E., Caon, Adriana C., Willenborg, David O., Clark-Lewis, Ian, and McColl, Shaun R.: A Role for macrophage inflammatory protein-3{alpha}/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system. J Immunol 170, 6298-(2003)
70. Karpus, W. J. and Ransohoff, R. M.: Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol 161, 2667-2671 (1998)
71. Ransohoff, R. M. and Bacon, K. B.: Chemokine receptor antagonism as a new therapy for multiple sclerosis. Expert Opin Investig Drugs 9, 1079-1097 (2000)